Edition:
United States

Hisamitsu Pharmaceutical Co Inc (HTSUF.PK)

HTSUF.PK on OTC Markets Group

47.20USD
--
Change (% chg)

-- (--)
Prev Close
$47.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
176
52-wk High
$55.52
52-wk Low
$46.30

Latest Key Developments (Source: Significant Developments)

Hisamitsu Pharmaceutical to set up subsidiary in China
Tuesday, 8 Aug 2017 03:07am EDT 

Aug 8 (Reuters) - Hisamitsu Pharmaceutical Co Inc <4530.T>:* Says it will set up a wholly owned subsidiary in China in August .* New subsidiary will be engaged in import and sale of pharmaceuticals.* New subsidiary will be capitalized at 1 billion yen.  Full Article

Hisamitsu Pharmaceutical's sales for March-May qtr seen down 8 pct - Nikkei
Thursday, 22 Jun 2017 01:06pm EDT 

June 22 (Reuters) - Nikkei: :Hisamitsu Pharmaceutical's group operating profit appears to have declined 13% on the year to just under 5 billion yen for March-May quarter - Nikkei.Hisamitsu Pharmaceutical's sales for March-May quarter are seen down 8% at about 35 billion yen - Nikkei.Hisamitsu Pharmaceutical Co Inc will likely maintain its forecast for the full year ending February 2018 - Nikkei.  Full Article

Hisamitsu Pharmaceutical repurchases 840,000 shares in October
Friday, 4 Nov 2016 02:08am EDT 

Hisamitsu Pharmaceutical Co Inc <4530.T>: Says it repurchased 840,000 shares for 4,520,864,000 yen in total from Oct. 18 to Oct. 31 . Says this was part of the share repurchase plan announced on April 8 .Says it repurchased 840,000 shares in total as of Oct. 31.  Full Article

Hisamitsu Pharmaceutical unit assigns rights for Brisdelle Capsules and Pexeva Tablets
Tuesday, 26 Jul 2016 03:12am EDT 

Hisamitsu Pharmaceutical Co Inc <4530.T>:Says its U.S.-based unit, Noven Pharmaceuticals, Inc., has reached agreement to assign rights of approval for manufacture, commercialization and associated intellectual property for Brisdelle(Paroxetine) Capsules, 7.5 mg and Pexeva(Paroxetine Mesylate) Tablets to Sebela International Limited.  Full Article

Hisamitsu Pharmaceutical says private placement of 1 mln treasury stocks
Friday, 8 Jul 2016 02:11am EDT 

Hisamitsu Pharmaceutical <4530.T>: Says it will distribute 1 million shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd. on Aug. 19 .Says it will raise 1 million yen in total through private placement.  Full Article

Hisamitsu Pharmaceutical sees sales down 4 pct to JPY 155 bln for FY 2017 - Nikkei
Monday, 27 Jun 2016 01:04pm EDT 

Nikkei: Hisamitsu Pharmaceutical's operating profit apparently took a 13 pct hit for the march-May Quarter - Nikkei . Hisamitsu Pharmaceutical forecasts sales falling 4 pct to 155 billion yen for the year ending February 2017 - NIKKEI .Hisamitsu Pharmaceutical likely earned around 5 bln yen ($49.2 mln) in profit for march-may quarter on a group basis - Nikkei.  Full Article

HISAMITSU PHARMACEUTICAL to issue year-end dividend for FY 2016
Friday, 8 Apr 2016 02:00am EDT 

HISAMITSU PHARMACEUTICAL CO INC:To issue a year-end dividend of 41 yen per share to all the shareholders of record as of Feb. 29, for FY ended Feb. 2016.Payment date May 27.Says latest dividend forecast was 40 yen per share.  Full Article

HISAMITSU PHARMACEUTICAL announces private placement of treasury stock; to repurchase shares
Friday, 8 Apr 2016 02:00am EDT 

HISAMITSU PHARMACEUTICAL CO INC:To distribute 1,000,000 shares of its treasury common stock at 1 yen per share through private placement to The Master Trust Bank of Japan, Ltd.To raise 1 million yen in total through private placement.Says it will repurchase up to 2,000,000 shares of its common stock, representing a 2.36 pct stake by Dec. 31.Share repurchase price is 12,000,000,000 yen in total.  Full Article

BRIEF-Hisamitsu Pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen - Nikkei

* Hisamitsu pharmaceutical's operating profit probably shrank 3 percent to 12.5 billion yen ($111 million) in the March-August period‍​ - Nikkei